David R. Bailey Sells 6,620 Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) CEO David R. Bailey sold 6,620 shares of the stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total value of $164,573.20. Following the completion of the sale, the chief executive officer now directly owns 319,155 shares of the company’s stock, valued at $7,934,193.30. This represents a 2.03 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

OrthoPediatrics Trading Down 1.1 %

Shares of OrthoPediatrics stock opened at $25.15 on Thursday. OrthoPediatrics Corp. has a 52-week low of $21.02 and a 52-week high of $35.99. The firm has a market capitalization of $610.82 million, a PE ratio of -20.45 and a beta of 1.22. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The company’s fifty day moving average price is $24.79 and its two-hundred day moving average price is $25.53.

OrthoPediatrics (NASDAQ:KIDS) last posted its earnings results on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.04. The business had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.16 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. During the same quarter in the previous year, the firm posted ($0.23) earnings per share. On average, analysts expect that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Hedge Funds Weigh In On OrthoPediatrics

A number of hedge funds have recently modified their holdings of KIDS. Wellington Management Group LLP grew its position in OrthoPediatrics by 20.2% in the fourth quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company’s stock valued at $24,601,000 after acquiring an additional 178,078 shares during the period. Wasatch Advisors LP raised its holdings in OrthoPediatrics by 47.2% during the 4th quarter. Wasatch Advisors LP now owns 696,318 shares of the company’s stock worth $16,141,000 after purchasing an additional 223,217 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in OrthoPediatrics by 29.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock worth $15,576,000 after purchasing an additional 152,681 shares during the last quarter. AWM Investment Company Inc. boosted its stake in shares of OrthoPediatrics by 14.8% in the 4th quarter. AWM Investment Company Inc. now owns 516,794 shares of the company’s stock valued at $11,979,000 after purchasing an additional 66,779 shares during the last quarter. Finally, Millennium Management LLC bought a new stake in shares of OrthoPediatrics during the 4th quarter valued at $9,798,000. 69.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Truist Financial reduced their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Stifel Nicolaus reduced their target price on shares of OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating for the company in a research note on Wednesday, March 5th. Finally, Needham & Company LLC restated a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research note on Wednesday, March 5th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.